Trials / Conditions / Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma
Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma
3 registered clinical trials studyying Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Suspended | Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma NCT04850495 | Yazeed Sawalha | Phase 1 |
| Suspended | Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diag NCT04799275 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |
| Completed | Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin NCT03210662 | M.D. Anderson Cancer Center | Phase 2 |